What is the role of the alternative renin-angiotensin system (RAS) in ACLD? 🤔
In this study we show:
✅systemic altRAS is upregulated in dACLD
✅intrahepatic altRAS is already activated in cACLD
❓potential target for specific therapies?
https://t.co/s6LzqHjICI
#livertwitter
"Trivial" IPMNs as potential target of surveillance discontinuation are out now on @AGA_Gastro 🔥
🧐 After 5 years of surveillance their risk comparable to that of the general population depending on
📏 Cyst size
👴 Patient Age
But how did we get here?
https://t.co/zUaNcwhssR
Please join me in celebrating Dr. Ammann for being awarded the #IHPBA Kenneth Warren Fellowship to join our Lab at #MayoClinic - thank you #IHPBA for this outstanding support to understand the relevance of circulating metabolites in liver regeneration #TELL
Extremely grateful for a chance to talk at #EASL2023 about liver function testing via APRI+ALBI and our international multicenter study, interesting discussion with great questions. Also, congrats to my colleague @TELL_kern for her presentation, stellar performance! #TELL
Extremely proud of our group members Jonas Santol and Anna Kern that had their ILC - #EASL talks yesterday - immensely impressed by their presentation and discussion, despite being just in the first year of residency and Anna ever still in medical school - so much more to come !
3 recent conferences - remarkable performance of TELL with a total of > 15 talks (crazy - all new data) and 2 awards - incredibly proud of the team - amazing performance - now off to EASL for even more entertainment - go #TELL@TELL_Santol@TELLpereyra
#EAHPBA2023 was amazing! Meeting colleagues from all over the world and attending together with my colleagues from #ClinicFavoriten and #TELL. Got to present our abstract on PHLF prediction via routine lab #APRIALBI Only possible because of international collaboration 🌍
Renee Adam @ #EAHPBA2023
⏩ Modern Cht for #CRLM is changing the sense of R0 resection
⏩ We need to consider that the cure is not really achievable in most of the cases
⏩Cytoreductive surgery + adj CHT can effectively boost OS by chronicizing the disease
@IHPBA@EAHPBA@hpb_so
Congratulations to @TELL_Starlinger, who I‘ve been fortunate enough to call a mentor for more than 5 years, for this amazing achievement. Thank you for your never-ending dedication and leadership to all of us at #TELL
Quite excited about this picture - #AHPBA and #MayoClinic bringing together residents from all over the world - Rochester, Arizona, Austria and Italy - thx @drsuswarner and @Seanpcleary for setting up this great social event to also foster future collaborations and friendship
Amazing time at #AHPBA23, getting the chance to connect with so many people as the „Austrian delegation“, always a pleasure to meet in person like this. Also, congratulations to @TELLRumpf and @TELLpereyra for their presentations on #TELLInternational research.
Happy to be able to present our project „Impact on single nucleotide polymorphisms on chemotherapy-associated steatohepatitis“ at the #AHPBA2023 in Miami! Thank you @TELL_Starlinger for providing this opportunity!
@TELLpereyra@TELL_Santol
Becoming an author in „The Bible“ of HPB surgery is certainly something I always dreamt of - another example of the limitless support of - the legend - David Nagorney - I learned so much from you David - thank you for all you did for me!
🚨📔Publication alert: The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation https://t.co/pLHwwRoMCY